129 related articles for article (PubMed ID: 33482232)
1. Modelling of late side-effects following cranial proton beam therapy.
Dutz A; Lühr A; Agolli L; Bütof R; Valentini C; Troost EGC; Baumann M; Vermeren X; Geismar D; Lamba N; Lebow ES; Bussière M; Daly JE; Bussière MR; Krause M; Timmermann B; Shih HA; Löck S
Radiother Oncol; 2021 Apr; 157():15-23. PubMed ID: 33482232
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours.
Dutz A; Lühr A; Agolli L; Troost EGC; Krause M; Baumann M; Vermeren X; Geismar D; Schapira EF; Bussière M; Daly JE; Bussière MR; Timmermann B; Shih HA; Löck S
Radiother Oncol; 2019 Jan; 130():164-171. PubMed ID: 30033385
[TBL] [Abstract][Full Text] [Related]
3. Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.
Dutz A; Lühr A; Troost EGC; Agolli L; Bütof R; Valentini C; Baumann M; Vermeren X; Geismar D; Timmermann B; Krause M; Löck S
Radiother Oncol; 2021 Jul; 160():69-77. PubMed ID: 33872640
[TBL] [Abstract][Full Text] [Related]
4. Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review.
Gaito S; Burnet N; Aznar M; Crellin A; Indelicato DJ; Ingram S; Pan S; Price G; Hwang E; France A; Smith E; Whitfield G
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e225-e237. PubMed ID: 35042622
[TBL] [Abstract][Full Text] [Related]
5. Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort.
Blanchard P; Wong AJ; Gunn GB; Garden AS; Mohamed ASR; Rosenthal DI; Crutison J; Wu R; Zhang X; Zhu XR; Mohan R; Amin MV; Fuller CD; Frank SJ
Radiother Oncol; 2016 Dec; 121(3):381-386. PubMed ID: 27641784
[TBL] [Abstract][Full Text] [Related]
6. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
[TBL] [Abstract][Full Text] [Related]
7. Assessing the uncertainty in a normal tissue complication probability difference (∆NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy.
Kobashi K; Prayongrat A; Kimoto T; Toramatsu C; Dekura Y; Katoh N; Shimizu S; Ito YM; Shirato H
J Radiat Res; 2018 Mar; 59(suppl_1):i50-i57. PubMed ID: 29538699
[TBL] [Abstract][Full Text] [Related]
8. Modelling the risk of radiation induced alopecia in brain tumor patients treated with scanned proton beams.
Palma G; Taffelli A; Fellin F; D'Avino V; Scartoni D; Tommasino F; Scifoni E; Durante M; Amichetti M; Schwarz M; Amelio D; Cella L
Radiother Oncol; 2020 Mar; 144():127-134. PubMed ID: 31805517
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive function and quality of life after proton beam therapy for brain tumour patients.
Dutz A; Agolli L; Bütof R; Valentini C; Baumann M; Lühr A; Löck S; Krause M
Radiother Oncol; 2020 Feb; 143():108-116. PubMed ID: 32044170
[TBL] [Abstract][Full Text] [Related]
10. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
[No Abstract] [Full Text] [Related]
11. Updating Photon-Based Normal Tissue Complication Probability Models for Pneumonitis in Patients With Lung Cancer Treated With Proton Beam Therapy.
Jain V; Niezink AGH; Frick M; Doucette A; Mendes A; Simone CB; Langendijk JA; Wijsman R; Feigenberg SJ; Levin W; Cengel KA; van der Schaaf A; Berman AT
Pract Radiat Oncol; 2020; 10(5):e330-e338. PubMed ID: 32416270
[TBL] [Abstract][Full Text] [Related]
12. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
[TBL] [Abstract][Full Text] [Related]
13. Dosemetric Parameters Predictive of Rib Fractures after Proton Beam Therapy for Early-Stage Lung Cancer.
Ishikawa Y; Nakamura T; Kato T; Kadoya N; Suzuki M; Azami Y; Hareyama M; Kikuchi Y; Jingu K
Tohoku J Exp Med; 2016 Apr; 238(4):339-45. PubMed ID: 27087118
[TBL] [Abstract][Full Text] [Related]
14. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.
Stokkevåg CH; Indelicato DJ; Herfarth K; Magelssen H; Evensen ME; Ugland M; Nordberg T; Nystad TA; Hægeland C; Alsaker MD; Ulven K; Dale JE; Engeseth GM; Boer CG; Toussaint L; Kornerup JS; Pettersen HES; Brydøy M; Brandal P; Muren LP
Acta Oncol; 2019 Oct; 58(10):1416-1422. PubMed ID: 31364899
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness of proton therapy in treating base of skull chordoma.
Austin AM; Douglass MJJ; Nguyen GT; Dalfsen R; Le H; Gorayski P; Tee H; Penniment M; Penfold SN
Australas Phys Eng Sci Med; 2019 Dec; 42(4):1091-1098. PubMed ID: 31646441
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive impairment following proton therapy for paediatric brain tumour: a systematic review of post-therapy assessments.
Yahya N; Manan HA
Support Care Cancer; 2021 Jun; 29(6):3035-3047. PubMed ID: 33040284
[TBL] [Abstract][Full Text] [Related]
17. Radiation-Induced Cerebral Microbleeds in Pediatric Patients With Brain Tumors Treated With Proton Radiation Therapy.
Kralik SF; Mereniuk TR; Grignon L; Shih CS; Ho CY; Finke W; Coleman PW; Watson GA; Buchsbaum JC
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1465-1471. PubMed ID: 30092336
[TBL] [Abstract][Full Text] [Related]
18. Acute toxicity of proton beam radiation for pediatric central nervous system malignancies.
Suneja G; Poorvu PD; Hill-Kayser C; Lustig RA
Pediatr Blood Cancer; 2013 Sep; 60(9):1431-6. PubMed ID: 23610011
[TBL] [Abstract][Full Text] [Related]
19. Mathematical Modelling for Patient Selection in Proton Therapy.
Mee T; Kirkby NF; Kirkby KJ
Clin Oncol (R Coll Radiol); 2018 May; 30(5):299-306. PubMed ID: 29452724
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
